Because Retatrutide is a new and advanced weight loss medication, it is more costly to produce than semaglutide and tirzepatide
[1][3] These symptoms are dose-dependent, meaning they tend to peak after starting treatment or stepping up to a higher dose, and they typically ease within several weeks as the body adjusts
Sebastian SA, Padda I, Johal G
En un estudio publicado el 2 de junio en la revista JCO Oncology Practice , las mujeres que tomaron GLP-1 tenan aproximadamente un 30% menos de probabilidades de desarrollar cncer de mama (en ingls) que aquellas que no los tomaron
International Journal of Sport Nutrition and Exercise Metabolism
[1] [3] Dizziness is a recognised adverse reaction in the Summary of Product Characteristics (SmPCs) for several GLP-1 medications, though the frequency varies between different products